Clinical Trial: Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Transthyretin Amyloidosis
Study Type: INTERVENTIONAL
Official Title: A Follow-Up Study to Monitor Therapeutic Response in Transthyretin Cardiac Amyloidosis Using Amyloid Reactive Peptide 124I-evuzamitide (AT01) PET/CT
Brief Summary:
This is a single center, prospective cohort study that is evaluating the ability of 124I-evuzamitide PET scanning to detect potential therapeutic changes in subjects under treatment for ATTR after one year has elapsed since their original 124I-evuzamitide PET scan.Ten previously scanned subjects will re-consent to undergo another 124I-evuzamitide PET scan.Demographic, clinical and phenotypic data will be collected to characterize potential changes since their previous scans.
Read more